Esperion Therapeutics

Price & Volume

Stats

52W Range	$1.58-$3.94
Market Cap	$431.5M
Shares Short	30M

Financials

Revenue (12 Mos)	$295.4M
Revenue Growth (YoY)	52%
Gross Profit (12 Mos)	-$70.4M
Diluted EPS	-$0.67

News

Yahoo Finance • 3 months ago

Is Esperion Therapeutics, Inc. (ESPR) the Best NASDAQ Stock Under $5?

Yahoo Finance • 8 months ago

11 Best Low Price Pharma Stocks To Invest In

Yahoo Finance • 12 months ago

Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including Resolution of Pending Litigation

Yahoo Finance • last year

U.S. FDA Updates LDL-C Lowering Indication for Esperion’s NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet

About

CEO	Mr. Sheldon L. Koenig
Address	3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Full-Time Employees	240